February 11, 2019: Viridium Pacific Group Ltd. (“Viridium”)(TSXV: VIR) (OTCPink: VIRFF) is pleased to announce it has completed the acquisition of EFX Laboratories Inc. (“EFX”) it previously announced on January 7, 2019, by way of an amalgamation of EFX and 2163903 Alberta Ltd., a wholly-owned subsidiary of Viridium, in accordance with the Business Corporations Act (Alberta) (the “Amalgamation”).

Viridium Pacific Group Ltd. ("Viridium")(TSXV: VIR) (OTCPink: VIRFF) is pleased to announce it has entered into an amalgamation agreement (the "Amalgamation Agreement") with EFX Laboratories Inc. ("EFX") relating to the acquisition by Viridium of all the issued and outstanding class A voting shares in the capital of EFX (the "EFX Shares") by way of an amalgamation of EFX and 2163903 Alberta Ltd., a wholly-owned subsidiary of Viridium, in accordance with the Business Corporations Act (Alberta) (the "Amalgamation").

While 38 percent of women worldwide suffer from chronic diseases, only 4 percent of research and development funding goes toward examining women’s health-care products and services. This leads women to seek out and experiment with alternative therapies, cannabis among them "The female reproductive system has the highest concentration of endocannabinoid receptors after the brain, making women particularly responsive to the medicinal properties of the plant.”

There has been much talk and debate about what cannabis legalization will look like in Canada. The effects to society – the economy, policing, public consumption, and the list goes on. The reality is come October 17, 2018 the world won’t look much different than it does today.

With a sophisticated black market, a host of regulatory controls, limited products and limited stores – what will Canadian cannabis legalization look like?